PHARMACEUTICAL FORMULATION - Patent 0862431

(19)

(11)

EP 0 862 431 A1

(12)

(43)	Date of publication:
	09.09.1998 Bulletin 1998/37

(21)	Application number: 96930817.0

(22)	Date of filing: 05.09.1996

(51)

International Patent Classification (IPC):

A61K 31/ 42^{( . )}
A61K 31/ 395^{( . )}
A61K 31/ 424^{( . )}
A61K 45/ 06^{( . )}
A61P 31/ 00^{( . )}

A61K 31/ 00^{( . )}
A61K 31/ 397^{( . )}
A61K 31/ 43^{( . )}
A61P 27/ 16^{( . )}
A61P 31/ 04^{( . )}

(86)	International application number:
	PCT/US1996/014554

(87)	International publication number:
	WO 1997/009042 (13.03.1997 Gazette 1997/12)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	SI

(30)

Priority:

07.09.1995 US 19950003353P

(60)	Divisional application:
	00203970.9 / 1093812

(60)	Divisional application:
	01201824.8 / 1147771

(71)	Applicant: SMITHKLINE BEECHAM CORPORATION
	King of Prussia, PA 19406-0939 (US)

(72)	Inventor:
	BURCH, Daniel, Joseph Collegeville, PA 19426-0989 (US)

(74)	Representative: Connell, Anthony Christopher, et al
	SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court Brentford, Middlesex TW8 9EP Brentford, Middlesex TW8 9EP (GB)

(54)	PHARMACEUTICAL FORMULATION